Correspondence 0001193125-23-079147 from GLOBUS MEDICAL INC (GMED) (CIK 0001237831) (GMED)
GLOBUS MEDICAL INC (GMED) (CIK 0001237831)
Date: March 24, 2023 · CIK: 0001237831 · Accession: 0001193125-23-079147
AI Filing Summary & Sentiment
File numbers found in text: 333-270482
Show Raw Text
CORRESP 1 filename1.htm CORRESP March 24, 2023 VIA EDGAR Office of Industrial Applications and Services Division of Corporation Finance U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Attention: Ms. Jane Park Re: Acceleration Request of Globus Medical, Inc. Registration Statement of Form S-4, as amended (File No. 333-270482) Dear Ms. Park: In accordance with Rule 461 under the Securities Act of 1933, as amended (the “Act”), Globus Medical, Inc. (the “Company”) hereby requests that the effective date of the above-referenced registration statement (the “Registration Statement”) be accelerated to Tuesday, March 28, 2023, at 4:15 p.m. Eastern Time, or as soon thereafter as practicable. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act. Once the Registration Statement is effective, please orally confirm the event with our counsel, Goodwin Procter LLP by calling Laura Umbrecht at (445) 207-7815. We also respectfully request that a copy of the written order from the Securities and Exchange Commission verifying the effective time and date of the Registration Statement be sent to our counsel, Goodwin Procter LLP, Attention: Laura Umbrecht, by email at LUmbrecht@goodwinlaw.com. [Signature Page Follows] Very truly yours, GLOBUS MEDICAL, INC. /s/ Daniel T. Scavilla Daniel T. Scavilla President and Chief Executive Officer cc: Kelly G. Hueller, General Counsel, Globus Medical, Inc. Rachael M. Bushey, Goodwin Procter LLP Jennifer L. Porter, Goodwin Procter LLP Laura K. Umbrecht, Goodwin Procter LLP